Skip to main navigation Skip to search Skip to main content

Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions

  • Vassilis G Gorgoulis
  • , Leandros-Vassilios F Vassiliou
  • , Panagiotis Karakaidos
  • , Panayotis Zacharatos
  • , Athanassios Kotsinas
  • , Triantafillos Liloglou
  • , Monica Venere
  • , Richard A Ditullio
  • , Nikolaos G Kastrinakis
  • , Brynn Levy
  • , Dimitris Kletsas
  • , Akihiro Yoneta
  • , Meenhard Herlyn
  • , Christos Kittas
  • , Thanos D Halazonetis
  • National and Kapodistrian University of Athens
  • Roy Castle Lung Cancer Foundation

Research output: Contribution to journalArticle (journal)peer-review

Abstract

DNA damage checkpoint genes, such as p53, are frequently mutated in human cancer, but the selective pressure for their inactivation remains elusive. We analysed a panel of human lung hyperplasias, all of which retained wild-type p53 genes and had no signs of gross chromosomal instability, and found signs of a DNA damage response, including histone H2AX and Chk2 phosphorylation, p53 accumulation, focal staining of p53 binding protein 1 (53BP1) and apoptosis. Progression to carcinoma was associated with p53 or 53BP1 inactivation and decreased apoptosis. A DNA damage response was also observed in dysplastic nevi and in human skin xenografts, in which hyperplasia was induced by overexpression of growth factors. Both lung and experimentally-induced skin hyperplasias showed allelic imbalance at loci that are prone to DNA double-strand break formation when DNA replication is compromised (common fragile sites). We propose that, from its earliest stages, cancer development is associated with DNA replication stress, which leads to DNA double-strand breaks, genomic instability and selective pressure for p53 mutations.

Original languageEnglish
Pages (from-to)907-13
Number of pages7
JournalNature
Volume434
Issue number7035
DOIs
Publication statusPublished - 14 Apr 2005

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Allelic Imbalance/genetics
  • Apoptosis
  • Cell Line, Tumor
  • Cell Transformation, Neoplastic/genetics
  • Checkpoint Kinase 2
  • Chromosome Fragility
  • DNA Damage/genetics
  • DNA Replication
  • Disease Progression
  • Enzyme Activation
  • Genes, p53/genetics
  • Genomic Instability/genetics
  • Histones/metabolism
  • Humans
  • Hyperplasia/enzymology
  • Intracellular Signaling Peptides and Proteins/metabolism
  • Mutation/genetics
  • Phosphoproteins/metabolism
  • Phosphorylation
  • Precancerous Conditions/enzymology
  • Protein Serine-Threonine Kinases/metabolism
  • Tumor Suppressor Protein p53/genetics
  • Tumor Suppressor p53-Binding Protein 1

Fingerprint

Dive into the research topics of 'Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions'. Together they form a unique fingerprint.

Cite this